Medtronic Debt Issuance/Retirement Net - Total 2010-2025 | MDT
Medtronic annual/quarterly debt issuance/retirement net - total history and growth rate from 2010 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
- Medtronic debt issuance/retirement net - total for the quarter ending January 31, 2025 was $2.139B, a 111.78% increase year-over-year.
- Medtronic debt issuance/retirement net - total for the twelve months ending January 31, 2025 was $8.939B, a 300.31% increase year-over-year.
- Medtronic annual debt issuance/retirement net - total for 2024 was $1.073B, a 279.43% decline from 2023.
- Medtronic annual debt issuance/retirement net - total for 2023 was $-0.598B, a 59700% increase from 2022.
- Medtronic annual debt issuance/retirement net - total for 2022 was $-0.001B, a 99.82% decline from 2021.
| Medtronic Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2024 | $1,073 |
| 2023 | $-598 |
| 2022 | $-1 |
| 2021 | $-570 |
| 2020 | $-559 |
| 2019 | $-867 |
| 2018 | $-7,598 |
| 2017 | $2,183 |
| 2016 | $-5,125 |
| 2015 | $18,673 |
| 2014 | $1,431 |
| 2013 | $-26 |
| 2012 | $601 |
| 2011 | $18 |
| 2010 | $2,536 |
| 2009 | $317 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $108.824B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||